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Introduction
Spinal cord injury (SCI), as a severe traumatic event that results in disturbances to normal sensory and motor function, is one of most important health problems worldwide with an annual incidence of 15 to 52.5 cases per million that appears to be rising (Singh et al., 2014) . Among these patients, up to 80% also develop chronic central neuropathic pain, a complication of SCI, which contributes to unemployment and depression (Hagen and Rekand, 2015) . Given the impact of SCI on these patients, effective clinical therapies that aim at improving neurologic outcomes and attenuating neuropathic pain after trauma are urgently needed.
It was reported that dietary restriction (Plunet et al., 2008) , intermittent fasting (Jeong et al., 2011) , ketogenic diet (Streijger et al., 2013) and exercise (Chang et al., 2014) improved functional recovery after contusion SCI. Interestingly, D-β-hydroxybutyrate (DBHB) levels were elevated during prolonged exercise, starvation or by the low carbohydrate ketogenic diet (Cotter et al., 2013) . DBHB, a ketone body mainly produced by hepatocytes, is an alternative source of energy when glucose supply is depleted by serving as alternative source of ATP (Newman and Verdin, 2014) . In vitro, DBHB prevented neuronal damage from glucose deprivation (Julio-Amilpas et al., 2015; CamberosLuna et al., 2016) and protected cultured mesencephalic neurons from MPP + toxicity and hippocampal neurons from Aβ(1-42) toxicity (Kashiwaya et al., 2000) . In vivo, DBHB treatment protected neurons in models of Alzheimer's disease, Parkinson's disease and Huntington's disease (Tieu et al., 2003; Lim et al., 2011; Xie et al., 2015) . Therefore, DBHB could represent an interesting approach for management of functional impairment and neuropathic pain in spinal cord-injured mice.
Methods

Animals
All animal care and experimental procedures complied with the Animals (Scientific Procedures) Act, 1986 of the UK Parliament, Directive 2010/63/EU of the European Parliament and the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication no. 85-23, revised 1996) and were approved by the Animal Welfare and Ethics Review Board of the University of Bristol, UK. Animal studies are reported in compliance with the ARRIVE guidelines (Kilkenny et al., 2010; McGrath and Lilley, 2015) . C57BL/6J (male, 12-weekold) mice were purchased from the Shanghai SiLaiKe Company (Shanghai, China). All the mice were housed with a 12 h light/12 h dark cycle at 22°C and free access to food and tap water.
Model of SCI and treatment
Before surgery, mice anaesthetized with ketamine and xylazine (80 and 10 mg·kg À1 , respectively, i.p.) and subcutaneously injected with prophylactic antibiotics (1 mg·kg À1 , Gentocin). The spinal cord was exposed by laminectomy at the T9-T10 vertebral levels, followed by a contusion simulating moderate-severe thoracic SCI using the Infinite Horizons Impactor (60 kdyn; Precision Systems and Instrumentation, Fairfax Station, VA, USA) (Jakeman et al., 2000) . Bladders were voided manually twice, and hydration was monitored daily. Mice receiving a laminectomy at the T9-T10 vertebral level without injury were used as sham controls. For continuous delivery of the DBHB (Sigma-Aldrich, MO, USA, 0.4, 0.8 and 1.6 mmol·kg À1 ·day À1 ), mini-osmotic pumps (Model 2001, ALZET; DURECT Corp., Cupertino, CA, USA) (Tieu et al., 2003; Lim et al., 2011) were implanted subcutaneously (1 μL·h À1 ) 6 h after surgery. Control mice were infused with sterile PBS.
Locomotor function and sensitivity to mechanical and thermal stimulation
All experimental mice were assessed using the Basso Mouse Scale (BMS), from 0 (no ankle movement) to 9 (normal gait), for scoring hindlimb function as previously described (Basso et al., 2006) . Mechanical allodynia and thermal sensitivity were recorded at times indicated post-SCI as the methods described previously (Hargreaves et al., 1988; Martucci et al., 2008; Hoschouer et al., 2010) (these data are shown in the Supplementary data). Experiments was performed without knowledge of the treatments (blinded). 
Western blotting analysis
Two weeks after surgery, 5 mm of tissue centred on the injury epicentre or equivalent area in sham-operated mice was manually dissected and homogenized in RIPA buffer and the proteins were extracted. Equal amounts of proteins (15 μg) were separated by SDS-PAGE and transferred to nitrocellulose membranes. The membranes were incubated overnight at 4°C with antibodies directed against α-AcH3K9 (Abcam), α-histone H3 (1:1000, Abcam), caspase-1 (1:1000, Santa Cruz), procaspase-1 (1:2000, Santa Cruz) and NLRP3
(1:800, Santa Cruz) and diluted in Tris-buffered saline-Tween 20 containing 1% non-fat dry milk. The loading control was β-actin (1:5000, Abcam).
Measurement of activity of histone deacetylases (HDACs)
Activities of HDAC in spinal cords were determined using the colorimetric HDACs activity assay kit (BioVision, Mountain View, CA, USA).
Quantitative RT-PCR analysis
Two weeks after surgery, 5 mm of tissue centred on the injury epicentre or equivalent area in sham-operated mice was manually dissected and total RNA was isolated using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) and 1 μg of total RNA was reverse transcribed with random primers by using a reverse transcription kit (QIAGEN, Shanghai, China) according to the manufacturer's protocol. Target cDNA levels were quantified by RT-PCR using specific primers:-(FOXO3a), 
Levels of IL-1β, IL-18 and malondialdehyde (MDA)
Two weeks after surgery, 5 mm of tissue centred on the injury epicentre or equivalent area in sham-operated mice was manually dissected and homogenized in RIPA buffer (50 mM Tris, 150 mM NaCl, 5 mM EDTA, 1% Triton-X 100, 0.1% SDS and 0.5% deoxycholate). Levels of IL-1β and IL-18 were determined by using ELISA kits (R&D Systems, Minneapolis, MN, USA). Levels of MDA (a presumptive marker of oxidant-mediated lipid peroxidation) were determined by using a kit (Cayman, Ann Arbor, MI, USA).
Measurement of myeloperoxidase (MPO) activity
MPO activity was an indicator of polymorphonuclear leukocyte accumulation, reflecting the number and distribution of neutrophils in the tissues. Tissues were homogenized in 50 mM potassium phosphate buffer (pH 6.0, 1:40 wt/vol) and incubated for 2 h; homogenates were then centrifuged (30 000 x g, 15 min), and supernatant was collected for measurement of MPO activity, as previously described (Mullane et al., 1985) .
Measurement of mitochondrial function
Mitochondrial respiration and ATP formation were measured according to the method described previously (Patel et al., 2009; Li et al., 2015) . Mitochondrial formation of H 2 O 2 and O 2 À was determined according to the method described by Elks et al., (2009) .
DBHB measurement
DBHB levels in spinal cord and serum were measured by using a DBHB Assay kit (MAK041; Sigma, MO, USA).
Data and statistical analyses
The data and statistical analyses comply with the recommendations on experimental design and analysis in pharmacology (Curtis et al., 2015) . The data are expressed as the mean ± SD. Differences among groups were assessed using one-way ANOVA, followed by Newman-Keuls post hoc tests, when F achieved the necessary level of statistical significance (P < 0.05) and there was no significant variance inhomogeneity. Data were significantly different at P < 0.05 according to the post hoc ANOVA analysis.
Results
Effects of administration of exogenous DBHB on locomotor function and neuropathic pain in mice exposed to SCI BMS scoring revealed that SCI mice showed markedly impaired motor function ( Figure 1A ) and decreased mechanical response threshold ( Figure 1B ) and thermal withdrawal latency ( Figure 1C ). DBHB treatment significantly promoted the recovery of motor function, and the effect was dose-dependent (Supporting Information  Table S1 ). Additionally, treatment of SCI mice with DBHB enhanced mechanical response threshold and thermal withdrawal latency, indicating that DBHB attenuated the hypersensitivity to mechanical and thermal stimulation in SCI mice.
Effects of administration of exogenous DBHB on loss of motor neurons and microglial and glial activation in mice exposed to SCI
As shown with immunofluorescence staining, the number of NeuN-positive cells was lower and the numbers of GFAP and IBA1-positive cells were higher in spinal cords of SCI mice than those in sham-operated mice (Figure 2A, B) . Treatment of SCI mice with DBHB enhanced number of NeuN-positive cells and reduced numbers of GFAP and IBA1-positive cells, indicating that DBHB prevented the loss of motor neurons and suppressed microglial and glial activation. The mRNA levels of NeuN were lower, and mRNA levels of GFAP and IBA1 were higher in injured region of SCI mice, which was partly reversed by treatment with DBHB ( Figure 2C ).
Effects of administration of exogenous DBHB on histone acetylation in spinal cord of mice exposed to SCI
To determine whether DBHB might have HDAC inhibitor activity, histone acetylation levels were measured by Western blotting with antibody to acetylated histone H3-lysine 9 (AcH3K9). SCI in mice led to a reduction of
Figure 1
Effects of treatment with DBHB (1.6 mmol·kg À1 ·day À1 ) on locomotor function and neuropathic pain in mice exposed to SCI. The time course of locomotor recovery evaluated by the 9-point BMS scoring (A) and sensitivities to mechanical (B) and thermal stimulation (C) after SCI are shown. Data are presented as the mean ± SD of eight mice per group. *P < 0.05, significantly different from sham-operated mice; #P < 0.05, significantly different from SCI mice.
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histone acetylation, but DBHB treatment enhanced histone acetylation in both sham-operated and SCI mice ( Figure 3A) . Furthermore, HDAC activities were higher in SCI mice than that in sham-operated mice, and treatment with DBHB reduced HDACs activities in both sham-operated mice and SCI mice ( Figure 3B ). SCI led to a marked reduction of mRNA expression of FOXO3a, SOD2 and catalase ( Figure 3C ), which was reversed by treatment with DBHB. DBHB treatment in sham-operated mice enhanced expression of FOXO3a significantly but expression of SOD2 and catalase was not significantly changed.
Effects of administration of exogenous DBHB on NLRP3 inflammasome activation in spinal cords of mice exposed to SCI SCI in mice resulted in up-regulation of NLRP3 protein expression ( Figure 4A ), activation of caspase-1 (Figure 4A ), up-regulation of expression of IL-1β ( Figure 4B ) and IL-18 ( Figure 4C ) and activity of MPO ( Figure 4D ). DBHB treatment in SCI mice reduced protein expression of NLRP3, activation of caspase-1, expression of IL-1β and IL-18 and activity of MPO, indicating that DBHB treatment could suppress NLRP3 inflammasome activation induced by SCI.
Figure 2
Effects of treatment with DBHB (1.6 mmol·kg À1 ·day À1 ) on loss of motor neurons and microglial and glial activation in mice exposed to SCI.
Pictures (A, B) showed the sections (3 mm rostral to the epicentre, scale bar = 20 μm) immuno-stained with antibodies recognizing NeuN, activated glia (GFAP) and microglia (IBA1). Samples of tissue (5 mm) centred on the injury epicentre or equivalent area in sham-operated mice were manually dissected for RT-PCR. Gene expression (C) of NeuN, GFAP and IBA1 measured by RT-PCR are shown. Data are presented as the mean ± SD of eight mice per group. *P < 0.05, significantly different from sham-operated mice; #P < 0.05, significantly different from SCI mice.
Figure 3
Effects of treatment with DBHB (1.6 mmol·kg À1 ·day À1 ) on histone acetylation in spinal cord of mice exposed to SCI. Samples of tissue (5 mm) centred on the injury epicentre or equivalent area in sham-operated mice were manually dissected for measurements. Western blotting results andcorresponding quantification (A) of α-AcH3K9 and α-histone H3 were shown. The histone acetylation was evaluated by calculating the ratio of α-AcH3K9/α-histone H3. Graphs show the activities of HDACs (B) in spinal cord of mice exposed to SCI. Gene expression (C) of FOXO3a, SOD2 and catalase measured by RT-PCR method are shown. Data are presented as the mean ± SD of eight mice per group. *P < 0.05, significantly different from sham-operated mice; #P < 0.05, significantly different from SCI mice.
Figure 4
Effects of treatment with DBHB (1.6 mmol·kg À1 ·day À1 ) on NLRP3 inflammasome activation in spinal cord of mice exposed to SCI. Samples of tissue (5 mm) centred on the injury epicentre or equivalent area in sham-operated mice were manually dissected for measurements. Western blotting results and corresponding quantification (A) of caspase-1, pro-caspase-1 and NLRP3 are shown. Graphs show the levels of IL-1β (B) and IL-18 (C) and activity of MPO (D). Data are presented as the mean ± SD of eight mice per group. *P < 0.05, significantly different from sham-operated mice; #P < 0.05, significantly different fromSCI mice.
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Effects of administration of exogenous DBHB on mitochondrial dysfunction in spinal cord of mice exposed to SCI When compared with sham-operated mice, mitochondrial respiration rates ( Figure 5A ) of states III and V were lower and mitochondrial ATP formation ( Figure 5B ) was suppressed in injured region of SCI mice. In addition, mitochondrial formation of O 2 À ( Figure 5C ) and H 2 O 2 ( Figure 5D ) and MDA levels ( Figure 5E ) in injured regions were higher in SCI mice than that in sham-operated mice. DBHB treatment in SCI mice led to enhancement of mitochondrial respiration rates and ATP formation, and reduction in mitochondrial formation of O 2 À and H 2 O 2 and MDA levels, indicating that DBHB treatment improved mitochondrial function and abated oxidative stress following SCI.
Levels of DBHB in serum and spinal cord of mice exposed to SCI and administration of exogenous DBHB
Immediately after mice were exposed to sham operation or SCI, pumps containing DBHB or PBS were implanted. Twenty-four hours later, the blood and spinal cords were collected for determination of levels of DBHB. SCI had no significant effect on levels of DBHB in serum ( Figure 6A ) and spinal cord ( Figure 6B ). Administration of exogenous DBHB enhanced levels of DBHB in serum and spinal cord in both groups. In DBHB-treated mice, levels of DBHB in spinal cords were lower in SCI mice than those in sham-operated mice, indicating that the utilization of DBHB was increased when the spinal cord was exposed to trauma.
Discussion
Our studies showed that infusion of the ketone body DBHB in mice conferred partial protection against SCI-induced motor deficits and neuropathic pain, accompanied by a significant preservation of motor neurons and suppression of microglial and glial activation. The ketone body DBHB is usually considered to be a convenient carrier of energy from the liver to peripheral tissues during fasting, caloric restriction or exercise. However, DBHB is not only a metabolite but also exerts important cellular signalling functions. DBHB was recently reported as an endogenous inhibitor of several HDACs including classes I and IIa (Shimazu et al., 2013) . HDACs remove the acetyl groups from acetylated histones, leading to a more condensed chromatin, usually associated with gene silencing. Increased mRNA and protein expression of HDAC3 has been observed in peripheral blood mononuclear cells of SCI patients . Furthermore, pharmacological inhibitors of HDACs have demonstrated potent therapeutic effects in animal models of SCI (Lv et al., 2011) . Following spinal nerve ligation, up-regulation of HDAC1 expression and reduction of histone H3 acetylation was associated with neuropathic pain (Cherng et al., 2014) . In vivo, treatment with HDACs inhibitors promotes axon regeneration (Finelli et al., 2013) . As previously reported (Lim et al., 2011; Shimazu et al., 2013) , DBHB treatment promoted acetylation of histone H3 in spinal cords. Consistent with inhibition of HDACs, DBHB correlated with global changes in transcription, including induction of FOXO3, in our experiments. Treatment of HEK293 cells with DBHB increased histone acetylation at the Foxo3a promoters and caused up-regulation of mRNA
Figure 5
Effects of treatment with DBHB (1.6 mmol·kg À1 ·day À1 ) on mitochondrial dysfunction in spinal cord of mice exposed to SCI. Samples of tissue (5 mm) centred on the injury epicentre or equivalent area in sham-operated mice were manually dissected for measurements. Graphs show the mitochondrial respiration rates (A) and formation of ATP (B), O 2 À (C) and H 2 O 2 (D) and MDA levels (E) in the injured site of spinal cord of mice exposed to SCI. Data are presented as the mean ± SD of eight mice per group. *P < 0.05, significantly different from sham-operated mice; #P < 0.05, significantly different from SCI mice.
expression of FOXO3a (Shimazu et al., 2013) . FOXO3a was also down-regulated in the injured region of SCI animals (Zhang et al., 2013) . Mitochondrial SOD2 and catalase are two well-defined targets of FOXO3a (Kops et al., 2002; Nemoto and Finkel, 2002) . In our experiments, DBHB treatment enhanced SOD2 and catalase gene transcription in spinal cord following SCI, which contributed to its effect on oxidative stress induced by SCI. Apart from oxidative stress, inflammation, manifested by extensive microglial and astroglial activation and infiltration of neutrophils and macrophages, was another contributor to post-traumatic neurodegeneration (Moghaddam et al., 2015) . The NLRP3 inflammasome, as an intracellular multiprotein complex involved in the activation of caspase-1 and the processing of the proinflammatory cytokines IL-1β and IL-18, is one of the most studied inflammasomes in the CNS (de Rivero Vaccari et al., 2014) . The cytokine IL-1β induced hypersensitivity to mechanical and thermal stimulation when it was injected into peripheral and central tissues (Gruber-Schoffnegger et al., 2013) , and the relationship between neuropathic pain and increased IL-1β levels in the spinal cord in several animal models has been described (Okamoto et al., 2001) . Recently, DBHB was found to reduce NLRP3 inflammasome-mediated IL-1β and IL-18 production in human monocytes andto attenuate NLRP3-mediated diseases including Muckle-Wells syndrome, familial cold autoinflammatory syndrome and urate crystalinduced peritonitis (Youm et al., 2015) . In our work, DBHB treatment suppressed SCI-induced NLRP3 inflammasomemediated IL-1β and IL-18 production and subsequent microglial and astroglial activation and infiltration of neutrophils and macrophages, which might contribute to the protective effects of DBHB on motor function recovery and neuropathic pain.
Changes in mitochondrial morphology and function, including energy production, free radicals, calcium overload and apoptosis, also play an important role in secondary damage following SCI (McEwen et al., 2011; Jia et al., 2016) . DBHB improved the mitochondrial defects by increasing mitochondrial function and ATP production in SOD1-G93A transgenic ALS mice (Zhao et al., 2006) and in the MPTPinduced model of Parkinson's disease (Tieu et al., 2003) . Kashiwaya et al. (2000) suggested that the neuroprotective effect of DBHB might be dependent on its ability to restore
Figure 6
Levels of DBHB in serum and spinal cord of mice. After animals were exposed to sham-operation or SCI, pumps containing DBHB (1.6 mmol·kg À1 ·day À1 ) or PBS were implanted. Twenty-four hours later, the sera (A) and spinal cords (B) were collected for determination of levels of DBHB. Samples of tissue (5 mm) centred on the injury epicentre or equivalent area in sham-operated mice were manually dissected for measurement. Data are presented as the mean ± SD of eight mice per group. *P < 0.05, significantly different from sham-operated mice; #P < 0.05, significantly different from SCI mice;^P < 0.05, significantly different from sham-operated mice treated with DBHB.
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the substrates for mitochondrial electron transport or its ability to decrease the production of ROS in the mitochondria. In our work, DBHB treatment of SCI mice enhanced mitochondrial respiration rates and ATP formation and reduced mitochondrial H 2 O 2 formation and MDA levels in the injured region. However, incubation of purified brain mitochondria with DBHB did not have antioxidant effects but increased ATP production (Tieu et al., 2003) , which indicated that the antioxidant property of DBHB was not dependent on its direct effect on mitochondria but might be dependent on its specific inhibition of HDACs and subsequent transcription of the genes encoding oxidative stress resistance factors as described above. Mitochondrial changes have been associated with NLRP3 activation in disease conditions. Mitochondrial dysfunction acted upstream of NLRP3 activation by providing ROS to trigger NLRP3 oligomerization, and mitochondria acted as a platform for inflammasome assembly (Ding et al., 2016; Yu and Lee, 2016) . Mitochondrial events might also lie downstream of NLRP3 activation (Zhuang et al., 2014; Yu and Lee, 2016) . Therefore, the effects of DBHB on NLRP3 activation and mitochondrial function could be expressed at several levels.
The short half-life of DBHB raises the question of whether this compound would be a feasible treatment in humans. In addition, therapeutic utility of such an approach in the clinical setting was not economical. DBHB has been given orally to two 6-month-old infants with persistent hyperinsulinaemic hypoglycaemia for 5 and 7 months (Plecko et al., 2002) . Despite the high dosage (up to 32 g·day À1 ), these patients appeared to tolerate the treatment quite well, without side effects. Whether oral administration of DBHB could be an effective means of achieving therapeutic levels against SCI, requires further work in animals and patients.
In conclusion, DBHB treatment partly reversed the trauma following SCI in mice. DBHB promoted functional recovery and relieved pain hypersensitivity in mice with SCI, possibly through inhibition of histone deacetylation and NLRP3 inflammasome activation and preservation of mitochondrial function.
